Comparative Evaluation between Sulfasalazine Alone and in Combination with Herbal Medicine on DSS-Induced Ulcerative Colitis Mice

Abstract

The present study aimed to investigate the comparative evaluation of pharmacological efficacy between sulfasalazine alone and sulfasalazine in combination with herbal medicine on dextran sodium sulfate- (DSS-) induced UC in mice. Balb/c mice received 5% DSS in drinking water for 7 days to induce colitis. Animals were divided into five groups (n = 9): Group I (normal group), Group II (DSS control group), Group III (DSS + sulfasalazine (30 mg/kg)), Group IV (DSS + sulfasalazine (60 mg/kg)), and Group V (DSS + sulfasalazine (30 mg/kg) + Cinnamomi Cortex and Bupleuri Radix mixture (30 mg/kg) (SCB)). Colonic pathological changes were analyzed using hematoxyline/eosin staining. The antioxidant, inflammatory, and apoptotic protein levels were determined using western blotting. SCB supplementation, as well as sulfasalazine, suppressed colonic length and mucosal inflammatory infiltration. In addition, SCB treatment significantly reduced the expression of proinflammatory signaling molecules through suppression of both mitogen-activated protein kinases (MAPK) and nuclear factor-kappa B (NF-κB) signaling pathways and prevented the apoptosis of the colon. Moreover, SCB administration significantly led to the upregulation of antioxidant enzymes including SOD and catalase. Taken together, SCB treatment might offer a better treatment for human UC than sulfasalazine alone or may be useful as an alternative therapeutic strategy against UC, without any evidence of side effects.

Protective Effects of Phellinus linteus Mycelium on the Development of Osteoarthritis after Monosodium Iodoacetate Injection

“…e protein levels of the groups are expressed relative to those of the normal rat (represented as 1). We followed the methods of Mi-rae Shin et al 2017 [36]. Evidence-Based Complementary and Alternative Medicine…”

Bacteriophages targeting intestinal epithelial cells: a potential novel form of immunotherapy

“…Oxidative stress has been suggested as a major contributing factor in the development of IBD: substantial evidence suggests that this syndrome represents a disturbed balance between increased reactive oxygen species (ROS) and decreased anti-oxidant activity. Anti-oxidant therapy was found to reduce disease activity in a mouse model of colitis [ 17 ]. However, clinical trials have not provided a conclusive answer; risks associated with compounds tested also inhibit further progress in this field [ 18 ]; phages are known to inhibit excessive ROS production [ 9 ], while phage therapy appears to be safe and relatively free of side effects [ 19 ].…”

Improvement of Oxazolone-Induced Ulcerative Colitis in Rats Using Andrographolide

“…This observation was because SASP was decomposed into 5-aminosalicylic acid, which plays a role in the treatment of UC, and sulfapyridine under the action of intestinal microbes after oral administration. However, the high-dosage administration and the long-term intake of sulfadiazine can cause severe side effects, such as headache, skin rash, blood disorders, folate deficiency, hepatotoxicity, hypospermia, and male infertility [48,49]. In addition, the experimental results suggested that the dosage of AND should be monitored to obtain the best therapeutic effect.…”